LETTER TO THE EDITOR
Comment on: Coexistence of systemic lupus erythematosus and familial Mediterranean fever in a pediatric patient Sir, We have read the article by Basaran et al. regarding coexistence of systemic lupus erythematosus (SLE) and familial Mediterranean fever (FMF) in a pediatric patient. 1 There are a few comments that we feel we need to make.
Firstly, we understand that the aforementioned patient had findings of SLE; however, FMF and SLE are diseases with clearly different pathogeneses (autoinflammatory versus autoimmune, respectively). 2, 3 It has been previously reported that mutations in the Mediterranean fever (MEFV) gene leading to an increased level of interleukin 1b, which is responsible for FMF, can contribute to other disease processes characterized by inflammation such as rheumatoid arthritis or Behc¸et's disease. 4 ,5 SLE, on the other hand, is characterized by formation of autoantibodies and organ damage. 3 Therefore, suggesting a meaningful coexistence of the two is difficult. Moreover, although cases of FMF have been reported in European countries and the United States, the endemic feature of FMF in Turkey (estimated prevalence being 1/1000), from where the authors have presented the case report, should not be forgotten. 6, 7 We agree that clinical features of FMF can be confounded with those of other rheumatic diseases. However, for our country Turkey, we believe that physicians should already have a low threshold for considering the diagnosis of FMF in a patient presenting with recurrent arthralgia and/or abdominal pain, even though the patient has additional atypical symptoms. Having consanguineous parents, and history of appendicitis (since many FMF patients have been misdiagnosed with appendicitis) are also key history findings to include FMF in the first place in the differential diagnosis of such a patient in our country, regardless of the additional findings. 8 In brief, because of the endemicity of FMF in Turkey, it may coexist with many diseases, including nonrheumatic diseases. Thus, it is essential to have a skeptical approach to these coexistences, question disease mechanisms, and be prudent when extrapolating such observations to other nations with different prevalence of FMF. On the other hand, two diseases have a different pathophysiological mechanism. Although bouts of peritonitis may seldom be seen in SLE, spontaneous remission of these bouts is rare and systemic findings usually accompany this picture. On the contrary, peritonitis in FMF generally resolves spontaneously in one to two days.
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